Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0185 | 0.1938 | 1 |
Echinococcus granulosus | glycylpeptide N tetradecanoyltransferase | 0.0181 | 0.189 | 0.9754 |
Echinococcus multilocularis | CREB binding protein | 0.0068 | 0.0595 | 0.3069 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0504 | 0.2477 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.0348 | 0.1661 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0032 | 0.0163 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0285 | 0.133 |
Onchocerca volvulus | 0.0048 | 0.0366 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0285 | 0.133 |
Leishmania major | N-myristoyl transferase, putative | 0.0181 | 0.189 | 1 |
Leishmania major | choline/Carnitine o-acyltransferase-like protein | 0.0156 | 0.1601 | 0.81 |
Echinococcus multilocularis | glycylpeptide N tetradecanoyltransferase | 0.0181 | 0.189 | 0.9754 |
Echinococcus granulosus | CREB binding protein | 0.0099 | 0.0953 | 0.4917 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0032 | 0.0163 |
Echinococcus granulosus | CREB binding protein | 0.0061 | 0.0516 | 0.2663 |
Loa Loa (eye worm) | choline/Carnitine O-acyltransferase | 0.0048 | 0.0366 | 0.1755 |
Giardia lamblia | CDC72 | 0.0181 | 0.189 | 0.5 |
Mycobacterium ulcerans | naphthoate synthase | 0.0888 | 1 | 0.5 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 1, liver | 0.0156 | 0.1601 | 0.826 |
Onchocerca volvulus | 0.0048 | 0.0366 | 0.5 | |
Brugia malayi | TAZ zinc finger family protein | 0.0099 | 0.0953 | 0.4833 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0156 | 0.1601 | 0.81 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0181 | 0.189 | 1 |
Echinococcus multilocularis | choline O acetyltransferase | 0.0185 | 0.1938 | 1 |
Schistosoma mansoni | CREB-binding protein 1 (SmCBP1) | 0.0099 | 0.0953 | 0.4833 |
Schistosoma mansoni | CREB-binding protein 2 | 0.0099 | 0.0953 | 0.4833 |
Echinococcus granulosus | carnitine O palmitoyltransferase 2 | 0.0048 | 0.0366 | 0.189 |
Onchocerca volvulus | 0.0048 | 0.0366 | 0.5 | |
Brugia malayi | Choline O-acetyltransferase | 0.0185 | 0.1938 | 1 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0181 | 0.189 | 1 |
Loa Loa (eye worm) | CBP-B | 0.0069 | 0.0605 | 0.3006 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.1601 | 0.8231 |
Schistosoma mansoni | choline o-acyltransferase | 0.0048 | 0.0366 | 0.1755 |
Mycobacterium tuberculosis | Naphthoate synthase MenB (dihydroxynaphthoic acid synthetase) (DHNA synthetase) | 0.0888 | 1 | 0.5 |
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.0181 | 0.189 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0285 | 0.133 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0504 | 0.2477 |
Brugia malayi | N-myristoyltransferase 2 | 0.0181 | 0.189 | 0.975 |
Onchocerca volvulus | 0.0048 | 0.0366 | 0.5 | |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0504 | 0.2477 |
Schistosoma mansoni | choline o-acyltransferase | 0.0185 | 0.1938 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0032 | 0.0163 |
Echinococcus granulosus | carnitine O palmitoyltransferase 1 liver | 0.0156 | 0.1601 | 0.826 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 2 | 0.0048 | 0.0366 | 0.189 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0504 | 0.2477 |
Loa Loa (eye worm) | carnitine O-palmitoyltransferase I isoform | 0.0048 | 0.0366 | 0.1755 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0032 | 0.0163 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0181 | 0.189 | 1 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0156 | 0.1601 | 0.8231 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0048 | 0.0366 | 0.1755 |
Loa Loa (eye worm) | N-myristoyltransferase 2 | 0.0181 | 0.189 | 0.975 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.0181 | 0.189 | 1 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0156 | 0.1601 | 0.81 |
Loa Loa (eye worm) | choline O-acetyltransferase | 0.0185 | 0.1938 | 1 |
Trypanosoma brucei | N-myristoyltransferase | 0.0181 | 0.189 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0032 | 0.0163 |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.0181 | 0.189 | 0.5 |
Brugia malayi | Choline O-acetyltransferase | 0.0185 | 0.1938 | 1 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0048 | 0.0366 | 0.1755 |
Echinococcus granulosus | choline O acetyltransferase | 0.0185 | 0.1938 | 1 |
Schistosoma mansoni | N-myristoyltransferase | 0.0181 | 0.189 | 0.975 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.0181 | 0.189 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0032 | 0.0163 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.